Evidence map›Paper›PMID 32279175›Full record

Observational studyAdvances in therapy2020

Hypothyroidism Treatment Among Older Adults: Evidence from a Claims Database.

Maureen J Lage, Ramon Espaillat, Jamie Vora, Zsolt Hepp

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Advances in therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Maureen J LageHealthMetrics Outcomes Research LLC, 27576 River Reach Drive, Bonita Springs, FL, 34134, USA.
Ramon EspaillatAbbVie, Inc., 26525 North Riverwoods Boulevard, North Chicago, IL, 60045, USA. ramon.espaillat@abbvie.com.
Jamie VoraAbbVie, Inc., 26525 North Riverwoods Boulevard, North Chicago, IL, 60045, USA.
Zsolt HeppAbbVie, Inc., 26525 North Riverwoods Boulevard, North Chicago, IL, 60045, USA.
AbbVie (United States) · USHealth Outcomes Solutions (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHypothyroidism is a common but often unrecognized condition associated with significant morbidity in the older adult population. This study characterizes a large population of older adults diagnosed with hypothyroidism and examines concordance of their treatment with recommendations from expert bodies, e.g., the American Thyroid Association and American Association of Clinical Endocrinologists.

methodsIndividuals seen in general and/or specialty practices who were age ≥ 65 years and diagnosed with hypothyroidism were included in this observational, retrospective cohort study using a large US claims database. Analyses describe the population and examine the prevalence of hypothyroidism, treatment with levothyroxine and, among those treated, whether TSH laboratory values are within a guideline-recommended target range.

resultsPrevalence of hypothyroidism in this older adult population increased from 5.62% to 8.24% over the 2007-2015 period. Among older adults diagnosed with hypothyroidism (N = 4025), a substantial proportion (28.0%) did not receive levothyroxine therapy, and, of those who were receiving such therapy (N = 2899), 32.9% did not have evidence of being monitored to determine whether the dosage was appropriate. Moreover, the laboratory results of those who were treated suggest that a significant proportion (17.4%) had a TSH level above the recommended target range, while TSH levels for a smaller proportion (3.7%) were below target.

conclusionsMany older adults diagnosed with hypothyroidism may not have received medical care complying with clinical practice guidelines. Results of this study reveal a number of areas to target to potentially improve the treatment of older adults with hypothyroidism.

Indexed as

Hormone Replacement TherapyHypothyroidismAgedDatabases, FactualFemaleHumansInsurance Claim ReviewMaleRetrospective StudiesThyroxineUnited StatesThyroxineHypothyroidismLevothyroxineOlder adultsTreatment

Identifiers

PMID32279175
PMCPMC7467444
OpenAlexW3015327284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.